The bronchiectasis drugs market consists of drugs used for the treatment of bronchiectasis. Bronchiectasis is a respiratory disorder characterized by abnormal, irreversible dilation of part or all of the bronchi in the lungs causing chronic cough with mucus. The increasing prevalence of respiratory diseases such as cystic fibrosis, chronic obstructive pulmonary disease (COPD), and asthma leading to bronchiectasis is a major factor driving the growth of the bronchiectasis drugs market. Drugs ... Read more
